Asset Allocation

As of March 31, 2026.
Type % Net
Cash 1.49%
Stock 97.51%
Bond 1.27%
Convertible 0.00%
Preferred 0.00%
Other -0.27%
View Asset Allocation
Start Trial

Market Capitalization

As of March 31, 2026
Large 8.33%
Mid 40.26%
Small 51.41%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 99.19%    % Emerging Markets: 0.00%    % Unidentified Markets: 0.81%

Americas 94.07%
92.55%
Canada 0.68%
United States 91.87%
1.51%
As of March 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 5.12%
United Kingdom 2.26%
2.50%
Ireland 2.03%
Netherlands 0.46%
0.00%
0.37%
Israel 0.37%
Greater Asia 0.00%
Japan 0.00%
0.00%
0.00%
0.00%
Unidentified Region 0.81%

Stock Sector Exposure

Cyclical
41.54%
Materials
5.79%
Consumer Discretionary
14.54%
Financials
15.12%
Real Estate
6.08%
Sensitive
36.28%
Communication Services
0.00%
Energy
8.29%
Industrials
18.08%
Information Technology
9.91%
Defensive
19.68%
Consumer Staples
5.16%
Health Care
9.80%
Utilities
4.72%
Not Classified
2.51%
Non Classified Equity
0.00%
Not Classified - Non Equity
2.51%
As of March 31, 2026
View Region Exposure
Start Trial

Stock Style Exposure

Large Cap Value --
Large Cap Core --
Large Cap Growth --
Mid Cap Value --
Mid Cap Core --
Mid Cap Growth --
Small Cap Value --
Small Cap Core --
Small Cap Growth --
No Data Available